NCT04508777View on ClinicalTrials.gov

COVID SAFE: COVID-19 Screening Assessment for Exposure

CompletedOBSERVATIONAL
Enrollment

1,759

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

December 8, 2020

Study Completion Date

June 23, 2021

Conditions
Covid19
Interventions
BEHAVIORAL

Saliva-based testing

Participants will take part in a voluntary COVID-19 screening program that includes bi-weekly saliva-based testing.

Trial Locations (1)

19103

Penn Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure | Biotech Hunter | Biotech Hunter